House Bill 1502

Relating to access to healthcare and Covid-19 vaccination status


What will this bill do?

  •  Prohibits a hospital from denying health care treatment or services to an individual based on COVID-19 vaccination status.

Read the bill.

Why is this bill needed?

  • Patients are being denied access to life-saving organ transplants due to their decision to not receive a covid vaccine. The reason given is to increase their chances of surviving an organ transplant. However, the data on covid vaccines show many safety signals that validate patients’ concerns.

    • CDC’s VAERS safety signal analysis for mRNA COVID-19 vaccines shows clear safety signals for death and a range of highly concerning thrombo-embolic, cardiac, neurological, hemorrhagic, hematological, immune-system and menstrual adverse events among U.S. adults.

      • The CDC analysis shows that the number of serious adverse events reported in less than two years for mRNA COVID-19 vaccines is 5.5 times larger than all serious reports for vaccines given to adults in the US since 2009.

      • There are 96 safety signals for 12-17 year-olds, which include: myocarditis, pericarditis, Bell’s Palsy, genital ulcerations, high blood pressure and heartrate, menstrual irregularities, cardiac valve incompetencies, pulmonary embolism, cardiac arrhythmias, thromboses, pericardial and pleural effusion, appendicitis and perforated appendix, immune thrombocytopenia, chest pain, increased troponin levels, being in intensive care, and having anticoagulant therapy.

      • There are 66 safety signals for 5-11 year-olds, which include: myocarditis, pericarditis, ventricular dysfunction and cardiac valve incompetencies, pericardial and pleural effusion, chest pain, appendicitis & appendectomies, Kawasaki’s disease, menstrual irregularities, vitiligo, and vaccine breakthrough infection

    • There are 12 new safety signals that indicate the danger of the COVID shots.

What is the current status of the bill?

HB 1502 was signed by the Governor on April 7th, 2023.